Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

TCT 673: Coronary Sinus Reducer for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

Presenter: Maayan Konigstein

October 27, 2024

$TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)$

Presentation TCT 2024

TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)

Presenter: Maayan Konigstein

October 27, 2024

Presentation TCT 2024

TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer

Presenter: Manel Sabate

October 27, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Advertisement

November 2024 Dispatch for the CV Team

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

TCT 673: Coronary Sinus Reducer for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)

TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

What’s Going to Be Hot at ACC 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content